SAVE THE DATE
On January 28th at 10 A.M EST (Duration : 2h)
Agenda:
- Introduction to ACC – Dr. Julie Hallanger Johnson, Moffit Cancer Center
- Mitotane treatment: Who, when and how long and management of the side effects related to Mitotane – Dr. Katja Kiseljak-Vassiliades, CU Anschutz Medical Campus Office of Inclusion and OutreachAnschutz Medical Campus, University of Colorado
- Patient Assistance Program for Mitotane – Ms. Kelly Price, Head of Rare Disease HRA Pharma
- When liver directed therapies are indicated in ACC – Dr. Venkatesh Krishnasamy, New York-Presbyterian / Columbia University Columbia University Irving Medical Center
- When surgery is indicated in metastatic ACC – Dr. Jonathan Hernandez, National Cancer Institute/National Institutes of Health
- When lung metastesectomy is indicated – Dr. Choung Hoang, National Cancer Institute/National Institutes of Health
- Medical management of metastatic disease and indications for radiation treatment – Dr. Tito Fojo, New York-Presbyterian / Columbia University Irving Medical Center
- Clinical Trials in ACC – Dr. Jaydi Del Rivero, National Cancer Institute/National Institutes of Health
- The Patient’s Voice/Advocate for Yourself – Ms. Jennifer Jeffries-Wright